Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2026
      • Abstracts
      • Dates and Deadlines
      • Exhibits
      • Housing and Travel
      • Sessions and Events
      • Registration
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2025
      • Neuroscience 2024
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct for SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2026 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct for SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (1)
  • (3)
  • (4)
  • (122)
  • (2)
  • (1)
  • (6)
Filter
31 - 40 of 189 results
  • Abstract
    Adolescent cocaine, vasopressin, and aggression in hamsters.
    Cocaine abuse during adolescence represents a significant health risk due to the potential for both acute and long-term negative physiological and psychological sequelae, including increased aggressive behavior. This study examines the hypothesis that chronic cocaine exposure during adolescent development predisposes hamsters to heightened levels of aggression by influencing the activity and expression of the arginine vasopressinergic (AVP) neural system in the anterior hypothalamus (AH), i.e., the brain region implicated in the regulation of aggression in golden hamsters (Mesocricetus auratus). To test this, male hamsters were treated with one of several doses of cocaine hydrochloride throughout adolescence (P27-56), then tested for offensive aggression in the absence or presence of AH-AVP receptor antagonists and examined for changes in AH-AVP expression and release on P57. Low dose cocaine treatment (0.5mg/kg/day) during adolescence significantly increased aggression intensity (number of attacks and bit...
    Nov 8, 2000
  • Abstract
    A rodent model of adolescent drug progression.
    Progression from drugs such as alcohol and tobacco to marijuana and 'harder' drugs is common in adolescents. To assess whether progression occurs in an adolescent rodent model, we dosed rats with 5% or 10% alcohol (EtOH), or water under pair-watered or free intake conditions, from PD21 to PD70 [designated PPA, pre- and peri-adolescent]. Fluid was available 1 hr daily, and both 5% and 10% EtOH induced high SECs. After dosing was concluded, we assessed carryover effects to later cocaine administration for three potential modes of carryover. Direct carryover effects were seen: PPA 5% EtOH significantly increased adult IV cocaine self-administration, 5% and 10% decreased cocaine conditioned place preference (reported at Neuroscience '99), and 5% and 10% altered cocaine-stimulated motor activity in a gender-specific manner. Acute withdrawal carrover effects were not observed on tests of cocaine-induced activity and schedule-induced polydipsia, with repeated testing during withdrawal from alcohol. Drug-associate...
    Nov 7, 2000
  • Abstract
    Adolescent cocaine, serotonin, and aggression in hamsters.
    Cocaine abuse during adolescence represents a significant health risk due to the potential for acute and long-term negative physiological and psychological sequelae, including increased aggressive behavior. This study examines the hypothesis that chronic cocaine exposure during adolescent development alters the expression and activity of the serotonergic (5-HT) neural system in the anterior hypothalamus (AH) (i.e., the brain region implicated in the regulation of aggression in golden hamsters [Mesocricetus auratus]), predisposing these animals to heightened levels of aggression as young adults. To test this, male hamsters were treated with one of several doses of cocaine hydrochloride throughout adolescence (P27-56), then tested for offensive aggression using the resident/intruder paradigm and examined for changes in the AH-5-HT neural system. Low dose cocaine treatment (0.5mg/kg/day) during adolescence significantly increased aggression intensity (number of attacks and bites) and initiation (decreased lat...
    Nov 8, 2000
  • Repetitive Mild Closed Head Injury in Adolescent Mice Is Associated with Impaired Proteostasis, Neuroinflammation, and Tauopathy | Journal of Neuroscience
    Repetitive mild traumatic brain injury (mTBI) in children and adolescents leads to acute and chronic neurologic sequelae and is linked to later life neurodegenerative disease. However, the biological mechanisms connecting early life mTBI to neurodegeneration remain unknown. Using an adolescent mouse repetitive closed head injury model that induces progressive cognitive impairment in males and anxiety in females in the absence of overt histopathology, we examined transcriptional and translational changes in neurons isolated from sham and injured brain in the chronic phase after injury. At 14 months, single-nuclei RNA sequencing of cortical brain tissue identified disruption of genes associated with neuronal proteostasis and evidence for disrupted ligand-receptor signaling networks in injured mice. Western blot analysis of isolated neurons showed evidence of inflammasome activation and downstream IL-1β processing, as previously demonstrated in acute CNS injury models, and accumulation of misfolded, hyperphos...
    Mar 23, 2022 Limin Wu
  • Repetitive mild closed head injury in adolescent mice is associated with impaired proteostasis, neuroinflammation, and tauopathy | Journal of Neuroscience
    Repetitive mild traumatic brain injury (mTBI) in children and adolescents leads to acute and chronic neurological sequelae and is linked to later life neurodegenerative disease. However, the biological mechanisms connecting early life mTBI to neurodegeneration remain unknown. Using an adolescent mouse repetitive closed head injury (CHI) model that induces progressive cognitive impairment in males and anxiety in females in the absence of overt histopathology, we examined transcriptional and translational changes in neurons isolated from sham and injured brain in the chronic phase after injury. At 14 months, single-nuclei RNA sequencing of cortical brain tissue identified disruption of genes associated with neuronal proteostasis and evidence for disrupted ligand-receptor signaling networks in injured mice. Western blot analysis of isolated neurons showed evidence of inflammasome activation and downstream interleukin-1 beta (IL-1β) processing, as previously demonstrated in acute central nervous system injury ...
    Feb 1, 2022 Limin Wu
  • Abstract
    Exaggerated locomotor responses to stimulants in adolescent rats.
    Most drug addiction begins during adolescence, but little is known about potential differences in the neural substrates for drug addiction in adolescent brain relative to adults. Our previous research has shown that adolescent rats display an exaggerated behavioral response to cocaine when it is administered in a “binge” pattern of closely spaced doses. These findings differ from other studies which report lower responses to single doses of amphetamine in adolescent rodents compared to adults. The purpose of the present study was to explore locomotor responses of adolescent rats to a variety of psychomotor stimulants to determine the generality of the exaggerated behavioral response to binge administration. Early (postnatal day 28, PN 28), mid (PN 42) or late (PN 65) adolescent male rats were treated with 3 doses of saline, nomifensine (NOM, 5 mg/kg), methylphenidate (MPH, 10 mg/kg) or amphetamine (AMP, 2 mg/kg) spaced at 2 hour intervals. The doses were chosen to elicit comparable levels of locomotor stim...
    Nov 16, 2005
  • Abstract
    Emotional and cognitive changes associated with adolescent development.
    Adolescence is a critical period for brain development. Although total cerebral volume does not increase substantially after childhood, there are progressive and regressive changes in the relative volumes of specific regions that occur as the brain engages in a process of fine-tuning its functional organization. Developmental changes in emotional processing and cognitive components of executive functioning also have been demonstrated during adolescence. Emotional experience is regulated by an integrated functional system that includes the neocortex and numerous subcortical limbic nuclei. Of these structures, the amygdala has consistently emerged as one of the most critical for ascribing emotional significance to stimuli and influencing affective responsiveness and emotional learning. Neuroimaging studies of adults have shown that the amygdala often produces increased activation in response to aversive conditioning and is activated consistently during the perception of fearful facial expressions. However, t...
    Nov 16, 2005
  • Abstract
    Gestational nicotine-induced changes in adolescent dopamine systems.
    We have previously shown that nicotinic acetylcholine receptors modulate release of both dopamine and norepinephrine in fetal brain. In the present study we have used both neurochemical and behavioral techniques to determine whether gestational nicotine (GN) treatment alters catecholamine transmission in adolescent brain. Pregnant dams were implanted with osmotic minipumps that delivered nicotine (3 mg/kg/day) or saline from gestational days 4 to 18. Male and female pups were cross-fostered to naïve, surrogate dams at birth. Norepinephrine (NET) and dopamine (DAT) transporter levels in the brains of adolescent offspring, aged postnatal day 32, were evaluated by autoradiography using [3H]nisoxetine and [125I]RTI-55 respectively. Quantitative analysis of radioligand binding revealed a significant effect of GN treatment on regional levels of DAT (F10, 40 = 3.9546, P <0.02), but not NET. The behavioral effects of cocaine were evaluated in both locomotor and self-administration studies. In GN animals, but not c...
    Nov 16, 2005
  • Persistent “Sag” in Prefrontal Cortex Function following Adolescent Binge Drinking | Journal of Neuroscience
    Binge drinking, intermittent periods with high levels of alcohol consumption, is common among human adolescents. Alcohol exposure during adolescence can exert persistent effects on brain maturation and increase the risk of developing an alcohol use disorder (AUD) later in life. One key brain region
    Nov 7, 2018 Max E. Joffe
  • Abstract
    Adolescent methamphetamine induces motor changes in adult rats.
    Several drugs of abuse have been shown to induce later continuing alterations in adult behavioral capabilities [see Smith, 2003]. To determine whether methamphetamine [METH] induces such neurobehavioral alterations, Long-Evans hooded rats were given 20 mg/kg/d METH from P22 through P56. After a 15 day washout period, animals were tested for 3 trials/day for 6 days in a Morris Water Maze task. METH animals demonstrated a significant reduction in swimming speed [F(1,25)=11.79, p <.01], averaging nearly 20% slower than controls. METH animals also tended to swim somewhat more direct paths to the platform location [p < .10], so that path length offset the slower swim speed, resulting in similar latencies to reach the platform. In addition, interaction effects for both latency and path length indicated that, while METH showed similar Trial A to Trial B improvement as controls, METH animals showed less improvement than controls from Trial B to Trial C. A follow-up day of MWM trials on P160 showed that METH animal...
    Oct 23, 2004
  • Previous
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Featured

  • Get involved with the SfN community
  • Discover what’s new at Neuroscience 2026!
  • Mihaela Iordanova Named Next eNeuro Editor-in-Chief
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Cookie Settings
  • Contact Us

Copyright ©
Society for Neuroscience